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Abstract
This paper studies the determinants of the regional disparities in the mortality of patients
treated in a hospital for a heart attack in France. These determinants can be some di¤erences
in patient characteristics, treatments, hospital charateristics, and local healthcare market
structure. We assess their importance with an exhaustive administrative dataset over the
1998-2003 period using a stratied duration model. The raw disparities in the propensity
to die within 15 days between the extreme regions reaches 80%. It decreases to 47% after
controlling for the patient characteristics and their treatments. In fact, a variance analysis
shows that innovative treatments play an important role. Remaining regional disparities are
signicantly related to the local healthcare market structure. The more patients are locally
concentrated in a few large hospitals rather than many small ones, the lower the mortality.
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1 Introduction
Spatial disparities in heath outcomes have become a major concern in France. A driver of these
disparities is often thought to be the missallocation of ressources caused by a lack of information
on local needs. As a consequence, a reform in 1996 decentralized the funding of the healthcare
system at the regional level. A global budget is now decided nationally before being dispatched
between regions. Some public regional agencies allocate the regional budgets between local public
and private not-for-prot hospitals after some bargaining.
Importantly, it is not obvious whether changing the regional budgets is likely to have a sizable
e¤ect on regional disparities in outcomes. The e¤ect will be signicant if supply factors (like
hospital capacities or equipments) are distributed unevenly over the territory and these factors
a¤ect health outcomes signicantly. By contast, changing regional budgets will have a far smaller
e¤ect if health outcomes are mainly the result of demand factors (like the age structure and socio-
economic habits). Also, the way regional agencies should allocate their regional budget between
hospitals is debatable. It is not clear-cut whether it is more e¢ cient to have a few well-equipped
hospitals which concentrate all the patients or many small hospitals which cover well the whole
regional territory.
In this paper, we quantify the spatial disparities in the mortality of patients treated in a hospital
for an acute myocardial infarction (heart attack). We then assess the importance of demand and
supply factors in explaining these disparities.
In the economic literature on health outcomes, most of the papers focus on the e¤ect of supply
factors, using demand factors only as controls. In that perspective, regional disparities in out-
comes may depend on the local management of patients after their admission in hospitals. This
management is related both to the quick admittance of patients in an adequate hospital and the
quality of care that they receive. A large literature focuses on the e¤ect of ownership on hospital
performance. Many authors compares for-prot and not-for-prot institutions (McClellan and
staiger, 2000; Hansman, 1996; Milcent, 2005). Some others study the change in ownership status
(Propper, Burgess and Green, 2004).1 However, these papers do not assess whether there is some
sorting of hospitals depending on their ownership status that could lead to spatial disparities in
performances. Also, they do not look much on the e¤ect of treatment quality provided by hospitals
on outcomes whereas there is an extensive literature in epidemiology on this issue for heart attack
1Other papers related to the topic include Newhouse, 1970; Cutler and Horwitz, 1998; Silverman and Skinner,
2001; Sloan et al., 1999; Ho and Hamilton, 2000; Kessler and McClellan, 2002.
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(see for instance Jollis et al., 1994). Some spatial disparties in the quality of treatments, possibly
related to the local proportions of hospitals in each ownership status, may cause some spatial
disparities in outcomes. We will address this kind of issues in our study.
In fact, the international literature on spatial health disparities is still scarce. There are some
comparisons between countries in the horizontal equity in health care utilization (see van Doorslaer
et al., 1997, 1999, 2000). However, for studies on a given country, space is usually not the main
topic and it is rather used as an extra-dimension to construct some instruments. For instance,
Geweke, Gowrisankaran and Town (2003) explain the hospital choice with the distance between
the place of residence and hospitals. There are a few exceptions like Mobley (2003) who studies
the e¤ect of the local healthcare structure on prices, but the emphasis is on healthcare acces
rather than on health outcome. Milcent (2005) evaluates the e¤ect of space on the mortality of
patients admitted in a hospital for a heart attack but only through the distance between the place
of residence and the hospital which is found to have a non-signicant e¤ect. In fact, it is quite
possible that the local healthcare market structure has an e¤ect on the local hospital performances.
We may think that local interactions and competition, as well as the local concentration of patients
in a few hospitals to benet from economies of scales, may a¤ect the local outcomes. These issues
deserve more attention.
By contrast, the literature on spatial disparities in the elds of economic geography and urban
economics has developed a lot in recent years. Some papers try to assess to what extent spatial
disparities in wages (Duranton and Monastiriotis, 2004; Combes, Duranton and Gobillon, 2008) or
unemployment (Gobillon, Magnac and Selod, 2007) can be explained with workerscomposition
e¤ects, rm e¤ects and true location e¤ects. We will borrow some tools from this literature as the
setting is quite similar.
For our study, we construct a unique matched patients-hospitals dataset from some exhaustive
French administrative records over the 1998-2003 period. This original dataset contains some
information on the demographic characteristics of patients, their diagnoses and their treatments.
It also provides some details on the hospitals where the patients are treated like the location, the
ownership status and the capacity. We show that regional disparities in mortality are quite large.
In particular, the raw di¤erence in the propensity to die within 15 days between the extreme
regions reaches 80%. We then assess whether these spatial disparities come from some local
di¤erences in patient characteristics (demographic shifters and secondary diagnoses), treatments,
hospital characteristics or healthcare market structure. We rst estimate at the patient level a
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Cox duration model stratied by hospital (i.e. each hospital has a specic baseline hazard) using
the Stratied Partial Likelihood Estimator proposed by Ridder and Tunali (1999). This estimator
allows to recover the e¤ect of the patient-specic variables (their characteristics and treatments)
while controlling for hospital unobserved heterogeneity. We then reconstruct the survival functions
of hospitals net of individual e¤ects and average them at the regional level. We nd that remaining
regional disparities are lower but are still signicant. The di¤erence in the propensity to die within
15 days between the extreme regions is now 47%. A variance analysis at the regional level shows
that regional di¤erences in innovative treatments play an important role.
We then assess to what extent the remaining regional disparities can be explained with some
hospital and geographic characteristics. For that purpose, we rst specify the hospital hazards
as the product of some hospital xed e¤ects and a baseline hazard. We show how to recover the
hospital xed e¤ects using some moment conditions. We then regress the hospital xed e¤ects
on some hospital and regional variables. Finally, we average the model at the regional level
and conduct a variance analysis. We nd that the local concentration of hospital supply plays a
signicant role. The more patients are concentrated in a few large hospitals rather than many
small ones, the lower the mortality. After hospital and geographic variables have been controlled
for, some unexplained regional disparities still remain.
In a rst section, we present how the French healthcare system deals with patients admitted
in a hospital for an acute myocardial infarction. A second section describes our dataset. We
then present in a third section some descriptive statistics on the regional disparities in mortality,
demand factors and supply factors. The fourth section details the econometric methodology used
to identify the causes of the regional disparities in mortality. The fth section summarizes the
results of the model.
2 Heart attack in the French context
2.1 Healthcare organization
In France, there are two types of ownership: public and private. For public hospitals, all in-
frastructures, equipments and sta¤ belong to the public sector. Investment in public hospitals
are nanced by public funding. The sta¤ (including doctors and nurses) consists in salaried civil
servants. For private hospitals, infrastructures, equipments and sta¤ belong to the private sec-
tor. The non-doctor sta¤ is salaried. Part of the doctor sta¤ is salaried and the other part is
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self-employed.
The public sector is under a global budget system. Part of the private sector is under the same
global budget system. Private hospitals which benet from this budget are called not-for-prot
hospitals (NFP). Every year, the government determines the global budget and chooses how to
divide it between regions (see Graph A1 for a map of the French regions). The regional budget is
dispatched between NFP and public hospitals through bilateral bargaining between the regional
regulator and the directors of hospitals. Since the Juppé reform in 1996, the bargaining power
of regional regulators has increased signicantly and regional local authorities have gained more
inuence on the regional hospital organization. NFP and public hospitals should grant access
to hospital care to every patients. They cannot make any prot. Hospitals in the private sector
(excluding NFP) are paid by fee-for-services and can select patients. The selection is usually
done to maximize prot taking into account the socio-economic caracteristics of patients (like
solvability) and their health. These hospitals have no constraint on prots and are called for-
prot hospitals (FP).
All these di¤erences suggest that hospitals have di¤erent incentives to provide health care to
patients depending on their status (public or private) and mode of reimbursment (fee-for-service
or global budget). This is particularly true for innovative procedures that are costly. Indeed, for-
prot hospitals are nanced via a fee-for-service system. Supplies such as stents are reimbursed
ex-post in addition to the fee-for-service payment. Doctors have an incentive to perform innovative
procedures as they receive additional fees for performing them. By contrast, it is more di¢ cult
for public and not-for-prot hospitals to purchase expensive devices as the public budget does not
account for costly innovative procedures (catheterization, angioplasty or stent). However, these
hospitals still perform some innovative acts (Dormont and Milcent, 2006). In fact, doctors may
have some indirect incentives to perform innovative procedures such as improving their reputation
or learning by doing.
Individuals do not have the same access to health care depending on the hospital status and the
mode of reimbursment. Patients are not charged in public hospitals except for a small out-of-
pocket but they incur charges in private hospitals. By contrast, for-prot hospitals x the price of
cattering and procedures, and patients are reimbursed on the basis of public hospital charges only.
The di¤erence between the price and reimbursment can be huge. The situation is intermediate in
not-for-prot hopitals as they only x the price of cattering.
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2.2 Treatments of heart attack
In this paper, we focus on one single disease. Indeed, evidence shows that the e¤ect of character-
istics (sex, age, ...) on mortality is disease-specic (Wray et al., 1997). We selected the Acute
Myocardial Infarction (heart attack) for four reasons. First, it belongs to the ischemic-disease
group that has been the primary cause of mortality in France, before getting second recently
after cancer. Second, mortality from AMI has been widely studied in the literature to assess the
quality of hospital care in the US and the UK. This literature can by used for comparison (see
Goworisakaran and Town, 2002, for the US, and Propper, Burgess and Green, 2004, for the UK).
Third, AMI is a well-dened pathology with only a few re-admission due to its clinical denition.
Fourth, mortality from AMI is an event frequent enough to yield some reliable statistical results.
We focus only on the stays of patients who arrived at the hospital after a heart-attack crisis. This
sample includes people who were told by their doctor to go to the hospital because of a heart
problem and those who were transferred from an emergency unit to a cardiac care unit. We leave
aside stays in emergency units when patients died or where sent back home. Indeed, the health of
patients in emergency units is usually not stabilized and these patients cannot be cured with the
usual treatments which are risky and can cause brutal death.
Before patients arrive at the hospital or when they just get in, they may receive thrombolytic
drugs. In the hospital, patients can benet from various treatments and procedures. These include
cardiac catheters (denoted as CATH hereafter), percutaneous transluminal coronary angioplasty
(PTCA), stent and bypass surgery. A catheter is a exible and thin pipe which is installed in
a vein to facilitate injections and drips. It may also be used to clean arteries to improve the
blood ow. A bypass surgery reroute, or bypass, is a vein or artery collected on the patients
body and set up to derive blood from coronary arteries to avoid clogged sections. It allows to
improve the blood ow and the oxygenation of the heart. The angioplasty and the stent are some
alternatives to the bypass to improve the blood ow in clogged arteries. They are used when
arteries are too clogged. An angioplasty consists in inating a balloon in a blockage to create a
channel. This procedure is costly as it induces for one stay an increase in costs which ranges from
30% to 60% (Dormont and Milcent, 2002). The stent is a spring-shaped prosthesis which is used
as a complement to angioplasty. It is put inside the balloon to keep the artery dilated. The use of
one or several stents with an angioplasty signicantly improves the results. We are going to study
the e¤ect of treatments over the 1998-2003 period. Angioplasties and stents were some innovative
treatments around 1998 and have generalized such that they are used at wide scale in 2003. In
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particular, the use of angioplasty with stent has increased from 15% in 1998 to 31% in 2003. In
this article, the term stent will refer to an angioplasty together with one or more stents, the term
angioplasty will refer to an angioplasty without stent, and the term catheterism will refer to a
catheterism without angioplasty and stent.
2.3 Spatial features
We now propose a spatial overview of heart attack. First note that patients who experience an
AMI and want to be treated in a NFP or a public hospital usually have to go to a hospital within
their region of residence. However, some patients are sometimes transferred to a neighbouring
hospital in another region. Also, a patient who gets sick in another region may be cured there.
Over the 1998-2003 period, the proportion of AMI patients treated within their region of residence
is very high at 92:9%. This proportion is slightly lower for for-prot hospitals (91:4%) than for
public hospitals (93:1%) and NFP (95:8%). Together with the regional organization of healthcare,
these statictics support the fact that regions can be viewed as local healthcare markets for heart
attack.
Depending on their residential location, patients do not face the same supply of healthcare as the
local composition of hospitals by status and mode of reimbursment varies widely across space. In
1999, the proportion of beds in public hospitals is large in Franche-Comté (in the east) where it
reaches 80% and in the west. By contrast, it is only 46% in the PACA region (in the southern
French Riviera). The proportion of NFP is the highest in some eastern regions at the German
border (Alsace and Lorraine) for historical reasons. Conversely, the proportion of beds in for-prot
hospitals is larger in the French Riviera where the population is older and richer.
The local ownership composition of bed capacities is closely related to the local ownership com-
position of hospitals where AMI patients are treated. Graph 1 shows that around Paris and in
southern regions, the proportion of patients treated in a for-prot hospital is higher. These regions
often provide more innovative treatments than the others, like stents as shown in Graph 2. In fact,
the rank correlation between the proportions of stents and AMI patients in for-prot hospitals is
:61. When considering NFP hospitals instead of for-prot hospitals, the correlation is still quite
high at :44.
[Insert Graphs 1 and 2]
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We also contructed the probability to die within 15 days (see Graph 3).2 This probability is
quite low in the Paris region, the east and south-east. It is larger in the west and south-west.
There is no obvious relationship between the probability to die and the proportions of stents
or for-prot hospitals (rank correlations:  :09 and :14 respectively). However, south eastern
regions which have a large proportion of for-prot hospitals performing innovative treatments
also concentrate older people who are more likely to die. Hence, it is necessary to perform an
econometric analysis to disentangle the e¤ect of age and more generally from individual attributes
(demographic characteristics and secondary diagnosis) from that of hospital composition and
treatments.
[Insert Graph 3]
3 The dataset
3.1 Data sources on patients, hospitals and areas
For our study, the primary dataset is the PMSI (Programme de Médicalisation des Systèmes
dInformation). This dataset provides the records of all patients discharged from any French
acute-care hospital over the 1998-2003 period. It is compulsory for hospitals to provide these
records on a yearly basis.3 Three nice features of this dataset are that it provides some information
at the patient level, it keeps track of hospitals across time, and it is exhaustive both for the public
and private sectors.4 A limit of the data is that patients cannot be followed across time if they
come back again later in the same hospital or if they change hospital.
The dataset contains some basic information on demographic characteristics of patients (age and
sex), as well as some very detailed information on diagnoses and treatments. In our analysis, we
can thus take into account all secondary coronary diagnoses as well as all technics used to cure
patients. The dataset also provides us with the type of entry (whether the patients come from
their residence, another care service in the same hospital or another hospital) as well as the type
of exit (death, home return, transfer to another hospital or transfer to another care service).
2See below for more details on how this probability was computed.
3An exception is local hospitals for which it is not compulsory. This does not a¤ect our study since these
hospitals do not take care of AMI patients.
4It should be mentioned however that only 90% of the private sector was covered in 1998 and 95% in 1999.
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We only keep patients whose pathology was coded as an acute myocardial infarction in the tenth
international code of disease (ICD-10-CM), i.e. the patients for which the code was I21 or I22.
Before 35, heart attacks are often related to a heart disfunction. As a consequence, we restrain
our attention to the patients more than 35 following thus the OMS denition. After deleting
observations with missing values for the variables used in our study (which are only a very few),
we end up with 421; 185 stays (in 1; 130 hospitals) over the 1998-2003 period.
We match our dataset with the hospital records from the SAE survey (Statistiques Annuelles des
Etablissements de santé) that was conducted every year over the 1998-2003 period. The SAE
survey contains some information on the municipality where each hospital is located, the number
of beds (in surgery and in total) and the number of days that beds are occupied (in surgery and
in total). The matching rate is very good and reaches 97% of the stays (which corresponds to
408; 592 stays in 1; 084 hospitals).
The municipality code in the SAE survey also allowed us to match our dataset with some variables
at the municipality level coming from other sources. These variables will be used in our estima-
tions as proxies to control for the municipality averages of individual unobserved socio-economic
characteristics. Indeed, the literature has shown that there can be some large socio-economic
disparities in health outcomes (see for instance Lindeboom and van Doorslear, 2004; Etilé and
Milcent, 2006). Our municipality variables include the municipal unemployment rate computed
from the 1999 population census, the median household income from the 2000 Income Tax dataset
and the existence of a poor area in the municipality (poor areas being dened by a 1997 law).
These indicators should (at least partially) capture some spatial di¤erences in lifestyle that can
have an impact on the health of patients and their propensity to die from AMI. Also, thanks to the
municipality code, we could identify the urban area in which hospitals are located.5 We computed
the local numbers of beds as a measure of the interactions between hospitals within a given urban
area. This variable also captures congestion e¤ects and we will be able to estimate only the e¤ect
of interactions net of congestion. We also computed a regional Herndahl index at the urban
area level using the number of patients in hospitals within each urban area. The Herndahl index
measures for a given urban area to what extent patients are equi-distributed between hospitals or
5An urban area is dened as an urban center (with more than 5,000 jobs) and the municipalities in its catch-
ment area. There are 359 urban areas in mainland France and they do not cover the whole territory (as some
municipalities are excluded and remain rural).
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concentrated within a few hospitals.6 When constructing urban area variables, we were confronted
with a few hospitals in municipalities which do not belong to any areas or to several of them. We
thus introduced some dummies for these two cases as controls. As we will use hospital variables
which should be time-invariant in our analysis (see Section 4 and 5), all hospital and geographic
variables are averaged across years. There are 406; 197 stays (in 1; 080 hospitals) for which we
have all the information on hospital and geographic variables.
We do not have any information on what happpened to transferred patients before their transfer.
In particular, we do not know how they were treated and how long they have already stayed in
a hospital. As a consequence, we restrict our attention to patients who come from their place
of residence. We end up with 341; 861 stays (in 1; 105 hospitals) for which all the information is
available on patient variables (and 331; 246 stays in 1; 060 hospitals for which all the information
is available on hospital and geographic variables).
3.2 Preliminary statistics
For each hospital, we then computed a gross survival function for exit to death using the Kaplan-
Meier estimator. This estimator treats other exits (home return and transfers) as censored. As
we are mostly interested in hospital disparities across regions, we computed the average survival
function by region.7 Observations were weighted by the number of patients still at risk in the
hospitals.8 We selected the region with the highest survival function (Alsace), the region with the
6The Herndahl index for an urban area u is Hu =
X
j2u

pj
pu
2
where j indices the hospitals, pj is the number of
patients in hospital j, and pu =
X
j2u
pj is the total number of patients within the urban area u. Hu increases from
1
Nu
to 1 as the concentration of patients increases, where Nu is the number of hospitals in the urban area u. Wen
Hu =
1
Nu
, the patients are equi-distributed between the Nu hospitals. When Hu = 1, they are all treated within
one hospital.
7We could have directly computed a survival function for each region. However, we believe that the relevant
unit at which the treatment of patients takes place is the hospital. Also, our approach at the hospital level parallels
the results obtained for the model presented in Section 5.
8When the length of stay increases, the number of patients in a given hospital decreases. Above a given length
of stay after which there is no patient at risk anymore, it is not possible to estimate the survival function. We
then arbitrary considered that the hospital survival functions remained constant after this length of stay. When
we compute the average survival functions by region, this assumption does not have much e¤ect for short/medium
length of stays. Indeed, only small hospitals do not have any patients at risk anymore for these lengths of stays.
As a consequence, we computed our descriptive statistics only for stays below fteen days to minimize the e¤ect
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lowest survival function (Languedoc-Roussillon), and the Ile-de-France region that corresponds
mostly to the Greater Paris Area and is the most densely populated. Graph 4 represents the
survival functions of these three regions as well as their condence intervals (Graph A2 in appendix
represents the survival functions for all the regions and Table A1 ranks the regions according to
their probability to die within 15 days). It shows that the average survival functions of any two
regions are signicantly di¤erent.
[Insert Graph 4]
Table 1 reports some disparity indices between regions in the probability to die within 1, 5, 10
and 15 days (dened as one minus the Kaplan-Meier). These indices are the max/min ratio,
the Gini index and the coe¢ cient of variation. The Gini indices and the coe¢ cients of variation
are computed in two stages. First, we compute the average of a given individual variable (for
instance, a death dummy) by region. Then, we compute the regional disparity indices for the
resulting variable (in our example, the share of deaths in the region), weighting the observations
by the number of patients in the region. The max/min ratio shows that regional disparities are
signicant. Indeed, the di¤erence in the probability to die within 15 days between the Maximum
(Languedoc-Roussillon) and the Minimum (Alsace) is 80%. However, more global indices like
the Gini index (0:07) and the coe¢ cient of variation (:218) remain quite small and suggest that
disparities are not systematic. Interestingly, disparities are a bit larger for the probability of death
within 1 day (Max/Min ratio of 94%). This may be due to di¤erent behaviours across regions in
transfers and home returns at early days of AMI.
The regional disparities may be explained with some spatial disparities in demand factors
(demographic shifters and secondary diagnosis) or in supply factors (treatments, characteristics of
hospitals and local healthcare market structure). The purpose of the paper is to disentangle these
two types of e¤ects. Potential candidates are built from patient and hospital variables aggregated
at the regional level. We now present some regional disparity indices for these candidates. We
mostly comment the results obtained for the Gini indices as they are global measures of disparities
and they are not sensitive to the level of magnitude as the max/min ratio (alternatively, we could
also comment the results obtained with the coe¢ cients of variation which are similar). In the
sequel, we will say to ease the presentation that disparities are small when the index is inferior
to :1, they are moderate for an index from :1 to :2, they are large for an index from :2 to :3, and
they are very large for an index above :3.
of our assumption.
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We rst consider variables related to patients which were averaged at the regional level. We
nd that there are signicant disparities across regions for some demographic variables: more
specically the Gini index is moderate for females aged 35   55 (:12) and males who are more
than 85 (:11). For diagnoses, disparities are often moderate or large, the Gini index reaching
:23 for surgical French DRGs (.23), :15 for the severity index and :13 for a history of vascular
diseases and for stroke. Note that the Gini index is most often moderate for diagnoses related
to specic behaviours before the heart attack such as obesity (:17), excessive smoking (:16), and
alcohol problems (:14). It is smaller for diabetes (:08). For treatments, disparities are often large
or very large. The Gini index reaches goes up to :53 for dilatations other than PTCA and :37 for
the cabbage or coronary bypass surgery. These two high disparity indices are not surprising as the
related treatments are (very) seldomly applied. More usual treatments like angioplasty and stent
still have a large Gini index which takes the value :28 and :21, respectively. Disparities are far
smaller for the catheter which is a more widespread treatment (:10).
Overall, the Gini indices show that potential explanations of disparities in the propensity to die can
be related to the three types of variables: demographic characteristics, diagnoses and treatments.
Our econometric analysis will determine which type of explanation has the largest explanatory
power.
[Insert Table 1]
We then computed regional disparity indices for the hospital and geographic variables used in
our regressions. Whereas hospital variables measure capacities and status (public, for-prot and
NFP), geographic variables are meant to capture scale economies and local interactions. For a
given variable, we constructed its regional average, weighting the observations by the number of
patients in the hospitals. The resulting regional average is then used to compute disparity indices
at the regional level. Results are reported in Table 2.
As previously, we only comment Gini indices. We begin with hospital variables. There are large
disparities across regions in the average size of hospitals measured by the total number of patients
(:23) or the number of AMI patients (0:27). Disparities are even larger for the number of beds (:49)
and the number of beds in surgery (:47). There disparities point out at some sorting of hospitals
according to their size. Finally, disparities are smaller but still large for the hospital status and
more specically for being a for-prot hospitals (:24).
We now comment the results for geographic variables. We observe some very large disparities
in the number of beds in in the urban area (Gini index :66). Disparties are also signicant for
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the Herndhal index computed at the urban area level (:20). Finally, regional disparities in
municipality variables used as proxies for unobserved demand factors are at best moderate, the
Gini index reaching :17 for the presence of a poor area in the municipality.
[Insert Table 2]
Overall, demand and supply factors both constitute potential candidate to explain the regional
disparities in mortality. We now present our empirical methodology to disentangle their e¤ects.
4 Econometric method
We rst give a brief description of the econometric model before turning to a more formal pre-
sentation of our approach. Even if we are interested in studying di¤erences in mortality across
regions, we build our model around hospital units. Indeed, hospitals have some specic behaviour
and e¢ ciency which should be properly accounted for to avoid misspecication biases. Hence, we
use a Cox duration model at the patient level stratied by hospital. This model contains some
patient-specic explanatory variables (demographic shifters, diagnoses and treatments), as well as
a specic survival function for each hospital which is left unspecied. Ridder and Tunali (1999)
explain how to estimate this model using the stratied partial likelihood estimator (SPLE) and
establish the theoretical properties of the estimators. Lindeboom and Kerkhofs (2000) apply their
methodology to quantify the e¤ect of school on job sickness of teachers and Gobillon, Magnac
and Selod (2007) use it to analyze the e¤ect of location on nding a job in the Paris region.
This methodology is more general than the ones usually used in the health literature on mortality
which take into account the hospital unobserved heterogeneity at best with hospital xed e¤ects
(Milcent, 2005). It can be applied even when the sample size and the number of hospitals are large
as in our case, whereas it is not even computationally possible to estimate directly some hospital
xed e¤ects. After estimating the hospital survival functions, we average them at the regional
level to study the regional disparities in mortality net of the e¤ect of patient-specic variables.
We then link the remaining regional disparities to some local di¤erences in hospital and geographic
characteristics. For that purpose, we make the additional assumption that the hospital hazards
write multiplicatively as the product of a hospital xed e¤ect and a baseline hazard. We show how
to estimate the hospital xed e¤ects using empirical moment conditions. We then explain these
xed e¤ects with hospital and geographic variables and nally average the model at the regional
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level to perform a regional variance analysis.9
We now present our approach more formally. For each patient, we observe the length of stay
in the hospital and the type of exit (death, home return or transfer). In the sequel, we only study
exit to death. All other exits are treated as censored. We specify the hasard function of a patient
i in a hospital j (i) as:
 (t jXi; j (i)) = j(i) (t) exp (Xi) (1)
where j () is the instantaneous hazard function for hospital j, Xi are the patient-specic explana-
tory variables and  are their e¤ect on death. Insofar, the hospital hazards are left completely
unspecied and allow for a very general study of regional disparities in death using regional av-
erages. Also, this semi-parametric approach avoids biases on the estimator of coe¢ cients  which
could arise from a misspecication of the hospital hazards. The model is estimated by stratied
partial maximum likelihood. The contribution to likelihood of a patient i who dies after a duration
ti is his probability to die conditionally on someone at risk in his hospital dying after this duration.
It writes:
Pi =
exp (Xi)X
i2
j(i)(ti)
exp (Xi)
(2)
where 
j (ti) is the set of patients at risk at day ti in hospital j, i.e. the set of patients that are
still in hospital j after staying there for ti days. The partial likelihood to be maximized then
writes: L = 
i
Pi. Denote b, the estimated coe¢ cients of patient-specic explanatory variables. It
is possible to compute the integrated hazard function j (t) of any hospital j using the Breslow
(1974)s estimator. It writes:
bj (t) = tZ
0
I (Nj (s) > 0)X
i2
j(s)
exp

XibdNj (s) (3)
where I () is the indicator function, Nj (s) = card 
j (s), and dNj (s) is the number of patients
exiting from hospital j between the days s and s+1. From the Breslows estimator, we compute a
survival function for each hospital j as exp( bj (t)) (an estimator of its standard error is recovered
9A tempting alternative approach is to estimate all the coe¢ cients in one stage only introducing all the patient,
hospital and geographic variables in a simple Cox model. However, such an approach does not take into account
the hospital unobserved heterogeneity. Consequently, standard errors of the coe¢ cients may be highly biased (see
Moulton, 1990). Our approach properly accounts for this issue.
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using the delta method). The hospital survival functions will be averaged at the regional level to
study regional disparities in mortality after any number of days.
We then study the determinants of hospital disparities by specifying the hospital hazard rates
in a multiplicative way:
j (t) = j (t) (4)
where j is a hospital xed e¤ect and  (t) is a baseline hazard common to all hospitals. We show
in appendix how to estimate the parameters using empirical moments derived from (4).10 Note
that we need an identifying restriction since j and  (t) can be identied separately only up to a
multiplicative constant. We impose for convenience that: 1
N
P
t
Nt (t) = 1 where Nt is the number
of patients still at risk at the beginning of day t and N =
P
t
Nt. After some calculations (see
appendix), we get:
 (t) =
 
1
N2
X
j;t
N jNtj (t)
! 1 
1
N
X
j
N jj (t)
!
(5)
j =
 
1
N j
X
t
Njt (t)
! 1 
1
N j
X
t
Njtj (t)
!
(6)
where Njt is the number of patients at risk at time t in hospital j, N j =
P
t
Njt, and the sum on t,P
t
, goes from t = 1 to t = T (here, we x T = 30 for convenience). It is possible to obtain some
estimators of  (t) and j replacing j (t) by the estimator bj (t) = bj (t)  bj (t  1) in the right-
hand side of equations (5) and (6). These estimators are denoted b (t) and bj. We show in appendix
10In doing so, we depart from the log-linear estimation method proposed by Gobillon, Magnac and Selod
(2007). Our approach is more adequate when exits are scarce as in our case. Indeed, Gobillon, Magnac and
Selod split the timeline into K intervals denoted [tk 1; tk]. Introduce k =
tkZ
tk 1
 (t) dt= (tk   tk 1) and yjk =
[j (tk) j (tk 1)] = (tk   tk 1). Integrating (4) over each interval and taking the log, they get: ln yjk = lnj +
ln k. yjk is not observed but can be replaced with a consistent estimator: byjk = hbj (tk)  bj (tk 1)i = (tk   tk 1).
The equation to estimate is then: ln byjk = lnj+ln k+ jk where  jk = ln byjk  ln yjk is the sampling error. This
equation can be estimated with standard linear panel methods. The authors use weighted least square where the
weights are the number of individuals at risk at the beginning of the interval. A limit of this method is that ln yjk
can be replaced by its estimator ln byjk only if byjk 6= 0. When it is not the case, observations should be dropped
from the sample. When implementing this approach to our case, this could be an issue as exits are scarce and a
signicant number of observations should be dropped when the time spent in the hospitals gets large. In practice
however, the results obtained with the two approaches are quite similar.
15
how to compute the covariance matrices of b = b (1) ; :::;b (T )0 and b = (b1; :::; bJ)0. We then
try to explain the hospital xed e¤ects with some hospital and geographic variables denoted Zj.
We specify: j = exp
 
Zj + j

where  are the coe¢ cients of hospital and geographic variables,
and j includes some unobserved hospital and geographic e¤ects. For a given hospital j, taking
the log and replacing the hospital xed e¤ect with its estimator, we get:
ln bj = Zj + j + j (7)
where j = ln bj   lnj is the sampling error on the hospital xed e¤ect. Equation (7) can be
estimated using weighted least squares where the weight is the number of patients in the hospitals.
Gobillon, Magnac and Selod (2007) explain how to compute the standard errors and propose a
R-square formula which accounts for the sampling error. We use their formulas in our empirical
application. Note that for a given hospital, equation (7) is well dened only when there is at least
one patient dying in the hospital over the 1998   2003 period (otherwise the quantity bj from
which we take the log would be zero). This condition may not be veried for hospitals that have
only a few patients. In fact, these hospitals have a negligible weight and they are dropped from
our sample. We nally average equation (7) at the regional level and conduct a variance analysis
for the resulting equation.
5 Results
Table 3 reports the estimation results of the rst-stage equation (1). The demographic character-
istics have the usual e¤ect on the propensity to die. Females are more likely to die than males.
This is consistent with care being more protective for males than for females possibly because
of biological di¤erences like the smaller target vessel size and the increased vessel tortuosity of
females (Milcent et al., 2007). However, the gender di¤erence is signicant only at younger ages
(between 35 and 55 year old). Also, the propensity to die increases with age.
The severity index is found to have a positive e¤ect on the propensity to die. Intuitively, one
also expects secondary diagnoses to have a positive e¤ect as they deteriorate health. This is true
empirically for renal failure, stroke, heart failure, conduction disease, alcohol. Other secondary
diagnosis have a more surprising negative e¤ect: diabetes, obesity, excessive smoking, vascular
disease, peripheral arterial disease, previous coronary artery disease, hypertension. These results
may be explained by preventive health care. Indeed, these secondary diagnoses may point out at
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patients who have been monitored more carefully before and after having a heart attack (Milcent,
2005).
All treatments have the expected negative e¤ect on the propensity to die: CABG, catheterism,
PTCA, other dilatation and stent. The stent, which is the most innovative procedure, has the
strongest negative e¤ect. After controlling for these treatments, the DRG index capturing the
heaviness of surgical procedures has a positive e¤et on the propensity to die. This can reect the
increased chances to die because of more cumbersome and risky surgery.
[Insert Table 3]
From the estimated coe¢ cients b, we constructed an integrated hazard for each hospital using
the Breslows estimator and averaged the corresponding hospital survival functions by region
(weighting by the number of patients at risk in the hospitals).11 Regions at extremes are the
same as when studying the raw data: Alsace (at the German border) usually exhibits the highest
survival function and Languedoc-Roussillon (in the South-East) the lowest. Graph 5 represents
the survival functions (as well as their condence intervals) for these two extremes and for Ile-
de-France (the Paris region).12 The di¤erence between the extreme regions are smaller but still
signicant.
[Insert Graph 5]
We quantify the regional disparities with the same indices as in the descriptive section 3.2 for
the probability to die within 1, 5, 10 and 15 days (dened as one minus the survival function of
the model). Results reported in Table 4 show that the di¤erence in the probability to die within
15 days between the extreme regions has decreased from 80% to 47% (this corresponds to a 41%
11This kind of aggregation is quite common in the labour literature. For instance, Abowd, Kramarz and Margolis
(1999) estimate a wage equation that includes some rm xed e¤ects. They then compute some industry xed e¤ects
as the averages of the estimated rm xed e¤ects for rms belonging to each industry (weighting the observations
by the number of workers in the rms).
12Graph A3 in appendix represents the survival functions for all the regions and Table A2 ranks the regions
according to survival after 15 days. Curves obtained with the model are not strictly comparable with those
obtained from raw data with the Kaplan-Meier estimator as instantaneous hospital hazards were normalized with
an ad-hoc rule. To get close to comparability, we multiplied instantaneous hospital hazards by a constant which was
chosen such that in absence of hospital heterogeneity (i.e. j (t) =  (t) for all t), the expected integrated hazard at
day 1 is equal to the expected integrated hazard obtained from the raw data (dened as minus the logarithm of the
Kaplan-Meier estimator). This normalization allows to obtain an average survival function of the same magnitude
as the one obtained from raw data with the Kaplan-Meier estimator.
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decrease). More systematic disparity indices like the coe¢ cient of variation and the Gini index
also decrease, but to a lesser extent (by 19% and 17%, respectively). In a variance-analysis spirit,
we dened a pseudo-R2 as one minus the ratio between the variance in the probability to die
within a given number of days computed from the model and the variance computed from raw
data. At 1 and 5 days, the pseudo-R2 is nearly 60%. Hence, explanatory variables would explain
more than half of the regional disparities in early death. However, it is lower at 10 days (48%),
and decreases even more to reach 40% at 15 days. This suggests that part of the early regional
disparities may be due to di¤erent timings of death events across regions. Also, there may be
some specic regional behaviours for transfers and home returns which would a¤ect the local
composition of patients and hence would have an impact on the di¤erence between the hospital
survival functions obtained from the model and from the Kaplan-Meier estimators. Interestingly,
the ranking of regions obtained for death within 15 days is not that di¤erent from the one obtained
from the raw data (unweighted rank correlation: :70). This means that controlling for individual
variables does not change much the ranking of regions.
[Insert Table 4]
We then supposed that each instantaneous hospital hazard writes multiplicatively as the product
of a hospital xed e¤ect and a baseline hazard. The parameters of the multiplicative model are
estimated using empirical moments as explained in the previous section. Graph 6 displays the
baseline hazard and the condence interval at each day. Remember that the weighted average
of the instantaneous baseline hazards is normalized to zero. We obtain that the baseline hazard
decreases sharply in the rst two days and then more smoothly until the eighth day. It remains
constant afterward. The sharp decrease just after entry in the hospital can be explained by violent
deaths that are quite common in early days of heart attack.
[Insert Graph 6]
We then regress the hospital xed e¤ects on a set of hospital and geographic variables. Results are
reported in Table 5 (estimated regional dummies corresponding to the specication of column 3 are
reported in Appendix A3). When we only introduce hospital variables (column 1), the adjusted-R2
is quite low at 0:13.13 It is larger at 0:23 when only geographic variables enter the specication
13This adjusted-R2 accounts for the sampling error and its formula is given in Gobillon, Magnac and Selod
(2007).
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(column 2). Interestingly, when introducing both groups of variables (column 3), the R2 at 0:28 is
below the sum of R2 of the two separate regessions (0:36), which suggests that variables are quite
correlated. Also, it is higher than the R2 of each separate regression, which suggests that each of
the two groups has some explanatory power of its own.
We now comment the sign of the estimated coe¢ cients for the full specication (column 3). We
nd that the propensity to die is nearly the same in for-prot hospitals and public hospitals. This
result may look surprising but it comes from the fact that we control for innovative treatments
(mainly angioplasty and stent). If we drop the variables related to innovative treatments from the
rst-stage specication, the propensity to die in public hospitals becomes higher than in for-prot
hospitals (see Table A3 in appendix). Hence, the higher e¢ ciency of for-prot hospitals would
come from a wider use of innovative treatments. We also nd that the propensity to die in a NFP
hospital is lower than in public or for-prot hospitals.
The proportion of patients in the hospital treated for an AMI has a negative and signicant e¤ect.
It is possible that hospitals concentrating AMI patients are specialized in heart-related pathologies
and thus have a higher e¢ ciency. The number of beds as well as their occupation rate have no
e¤ect on mortality. The propensity to die is lower in hospitals with a higher proportion of beds
in surgery (whether controlling for innovative treatments or not). In fact, hospitals with a high
proportion of beds in surgery could be specialized in serious diseases and have a higher quality
sta¤. The propensity to die also decreases with the occupation rate of beds in surgery (signicantly
at 10% only). It is possible that hospitals with a high occupation rate are also those which are
the more e¢ cient and the more likely to attract patients.
Among municipal variables, the presence of a poor area has a positive e¤ect (signicant at 10%) on
the propensity to die, whereas the median income and the unemployment rate have no signicant
e¤ect. The positive e¤ect of the presence of a poor area can be explained with a deterioted health
of local people (the general health status being not captured with diagnoses variables).
The number of beds in the urban area has a positive signicant e¤ect which turns out to be
negative but not signicant when innovative treatments are not controlled for. An interpretation
can be that larger markets propose more innovative treatments but also yield more congestion.
These two e¤ects would compensate but after controlling for the innovative treatments, only the
congestion e¤ects would remain. The Herndahl index for the number of patients across hospitals
computed at the urban area level has a signicant negative e¤ect. This result suggests that the
fewer the hospitals in which patients are concentrated, the lower the propensity to die.
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Finally, regional dummies always have a negative e¤ect compared to the reference (Languedoc-
Roussillon) and their e¤ect is most often signicant. Di¤erences may be explained by unobserved
regional factors such as the regional di¤erences in the propensity to transfer patients when they are
likely to die. Indeed, recall that we work only on patients who come from their place of residence
and not from a transfer. Note that standard errors are quite large and two regions should be far
enough in the distribution of regional e¤ects for the di¤erent between their e¤ects to be signicant.
The ranking of regional e¤ects is nearly uncorrelated with the probability to die within 15 days
obtained from raw data (unweighted rank correlation: :02) and with that obtained from the model
(unweighted rank correlation:  :11).
[Insert Table 5]
We now perform a variance analysis at the regional level. Taking the logarithm of equation (1)
under the multiplicative assumption (4), and computing the average for any region r gives:
1
N r
X
ijj(i)2r
ln (t jXi; j (i)) = Xr + lnr +  (t)
whereN r is the number of patients in region r, X
r
is the regional average of individual explanatory
variables and ln
r
is the regional average of hospital xed e¤ects weighted by the number of
patients in the hospitals. It is possible to qualitatively assess the relative explanatory power of
right-hand side terms computing their variance and their correlation with the left-hand side term
(see Abowd, Kramarz and Margolis, 1999). In fact, the larger the variance and the correlation,
the higher the explanatory power. In practice, as  and ln
r
are not observed, we use their
estimators b and dlnr (the latter being dened as the weighted average of [lnj) to compute
the right-hande side terms. An estimator of the left-hand side term is obtained from the sum of
right-hand side terms. Using the same approach, we also assess the explanatory power of X
r
s
b
for some sub-groups X
r
s of explanatory variables. Importantly, note that this procedure measures
the explanatory power ex ante before any ltering process of patients through tranfers or home
returns. We can further assess the explanatory power of hospital and geographic variables. Taking
the log of the expression of hospital xed e¤ects and averaging at the regional level, we get:
ln
r
= Z
r
 + r
where Z
r
and r are the regional averages of explanatory variables and random terms, respectively.
We can assess the explanatory power of Z
r
 and Z
r
s, for some sub-groups Z
r
s of explanatory
variables, in the same way as for individual variables (replacing  by its estimator).
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We nd that individual variables have a far larger power than hospital e¤ects in explaining re-
gional disparities in mortality (see Table 6a). Indeed, their variance is ve to six times larger.
Interestingly, among the individual variables, it is the innovative treatments which have the largest
explanatory power. This means that regional disparities in innovative treatments are a key fac-
tor in explaining regional disparities in mortality. This has some important consequences for the
regional funding of innovative equipments. Of course, the age-and-sex regional composition also
plays a role. Interestingly, the hospital and geographic e¤ects have a larger variance than the
composition e¤ects, which suggests that their role in explaining regional disparities is signicant.
Note that the sum of variances for groups of individual variables is far smaller than their sum.
This comes from fairly large correlations between groups. In particular, regions where patients
are aged and mostly females are also those in which more innovative treatments are performed
(correlation between the demographic e¤ects and the e¤ect of innovative treatments: :57).
When trying to explain regional disparities in hospital xed e¤ects, we nd that hospital variables
do not have much explanatory power (Table 6b). In particular, the local composition of ownership
status does not play much. By contrast, geographic variables have a large explanatory power.
The local size of the market (measured by the local number of beds) and the local concentration
of patients play a signicant role.14 This is not the case of municipality variables. Finally, residual
local e¤ects captured by regional dummies have a large variance. This means that some regional
unobserved factors have a large e¤ect on regional disparities in AMI death.
[Insert Table 6a and 6b] (8)
6 Conclusion
In this paper, we studied the regional disparities in mortality for patients admitted in hospitals
for a heart attack. This was done using a unique matched patients-hospitals dataset over the
1998-2003 period constructed from exhaustive administrative records. For patients, this dataset
contains some information on demographic characterics (sex and age), diagnoses and treatments.
For hospitals, it gives some details on the location, the status, the mode of reimbursment and the
14Note that the local size of the market and the local concentration of patients have an e¤ect that is positively
correlated with hospital xed e¤ects. However, their correlation with the overall integrated hazard (last column in
Table 6b) is negative. This is because these e¤ects are more than compensated by regional xed e¤ects and the
e¤ects of innovative treatments.
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capacity.
We showed that regional disparities are fairly large. The di¤erence in the propensity to die between
the extreme regions reaches 80%. We analyzed the causes of these disparities using a Cox duration
model stratied by hospitals. This model allows for a specic hospital baseline hazard and controls
for individual observed heterogeneity. Hence, it captures di¤erences in hospital behaviours when
treating the patients. The survival functions of hospitals were averaged at the regional level
to assess whether there are still some regional disparities after individual variables have been
controlled for. Regional disparities decrease but remain signicant: the di¤erence in the propensity
to die between the extreme regions is still 47%. Interestingly, the extent to which patients are
treated with innovative procedures at the regional level plays a major role in the decrease of the
disparities.
We then assessed to what extent the remaining regional disparities could be explained with the
local composition of hospitals and geographic e¤ects. This was done regressing hospital hazards
on hospital and geographic variables, and averaging the model at the regional level. We found
that once treatments have been controlled for, hospital variables do not play much. By contrast,
geographic variables, and in particular the local concentration of patients, play a signicant role.
The more patients are concentrated in a few large hospitals rather than many small ones, the lower
the mortality. After hospital and geographic variables have been controlled for, some signicant
regional disparities still remain.
The scope of our analysis is limited because patients were not tracked in the data when they
were transferred to another hospital. For patients who were transferred, we had to consider
that the length of stay was censored. An interesting extension of our work would be to study
the strategic behaviour of hospitals when transferring patients. Indeed, some hospitals may try to
minimize their mortality rate by transferring the patients who are the most likely to die even when
they are well equipped and can conduct some innovative treatments. Others, like local hospitals,
may try to increase the propensity to survive of some patients by sending then to more e¢ cient
establishments. It should be possible to conduct such an analysis in the future when data tracking
patients (which exist) will be made available for research.
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7 Appendix: second-stage estimation
In this appendix, we explain how to construct some estimators of the baseline hazard and hospital
xed e¤ects. We rst average equation (4) across time, weighting the observations by the number
of patients at risk at each date. We obtain:
1
N
X
t
Ntj (t) = j
1
N
X
t
Nt (t)
where Nt is the number of patients at risk at the beginning of period t, N =
P
t
Nt with
P
t
the
sum from 1 to T days (with T = 30 in the application). A natural identifying restriction is that
the average of instantaneous hazards equals one: 1
N
P
t
Nt (t) = 1. We obtain:
j =
1
N
X
t
Ntj (t) (9)
It is possible to construct an estimator of hospital xed e¤ects from this formula, but weights
(namely: Nt) are not hospital-specic and thus do not reect hospital specicities. Hence, we
propose another estimator of hospital xed e¤ects in the sequel which we believe better capture
hospital specicities.
We also average equation (4) across hospitals, weighting by the number of patients at risk (summed
across all dates) in each hospital. We get:
1
N
X
j
N jj (t) =
1
N
 X
j
N jj
!
 (t)
where N j =
P
t
Njt with Njt the number of patients at risk in hospital j at the beginning
of date t (such that N =
P
j
N j). Replacing j with its expression (9), we obtain:  (t) = 
1
N2
P
j;t
N jNtj (t)
! 1 
1
N
P
j
N jj (t)
!
. An estimator of the hazard rate at date t in hospital j
can be constructed from the Breslows estimator such that bj (t) = bj (t)  bj (t  1). A natural
estimator of the baseline hazard is then:
b (t) =  1
N2
X
j;t
N jNtbj (t)! 1 1
N
X
j
N jbj (t)!
We then construct an estimator of a given hospital xed e¤ect j averaging equation (4) across
time for this hospital and weighting by the number of patients at risk at the beginning of each
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day in this hospital. We obtain:
1
N j
X
t
Njtj (t) = j
1
N j
X
t
Njt (t)
An estimator of the hospital xed e¤ect is then:
bj =  1
N j
X
t
Njtb (t)! 1 1
N j
X
t
Njtbj (t)! (10)
We also computed the asymptotic variances of b = b (1) ; :::;b (T )0 and b = (b1; :::; bJ)0, denoted
V et V, with the delta method. Indeed, the covariance matrix of bJ = b1 (1) ; :::;bJ (T )0 can be
estimated from Ridder et Tunali (1999). Its estimator is denoted bVJ . We can then compute the
estimators: bV =  @b
@b0J
 bVJ  @b0@bJ  and bV =  @b@b0J  bVJ  @b0@bJ . The vectors @b@bJ and @b@bJ are given
by:
@b (t)
@bk () = NN
kP
j;t
N jNtbj (t)1ft=g   NN
kN"P
j;t
N jNtbj (t)#2
X
j
N jb (t) (11)
@bj
@bk () = NkP
t
Nj;tb (t)1fk=jg   bj
P
t
Nj;t
@b(t)
@bk()P
t
Nj;tb (t) (12)
In practice, to simplify the computations, we neglected the second term on the right-hand side
of (12). This is only a slight approximation that does not have much impact on the estimated
variance of bj. It amounts to neglect in (10) the variations of 1NjP
t
Njtb (t) with respect to the
terms bj (t) compared to the variations of 1NjP
t
Njtbj (t) which is far larger. Put di¤erently, b (t)
is supposed to be non-random in (10).
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Table 1: disparity indices 
for the regional averages of individual variables 
 
 
 
Mean 
 
Min 
 
Max 
 
Max/Min
 
Std. Dev. 
 
Coeff. of 
variation 
Gini 
 
Number of AMI patients 21448 6335 44393 7.008 11534 0.538 0.295 
Death 0.080 0.059 0.098 1.675 0.0098 0.123 0.070 
Female, 35-55 year old 0.024 0.015 0.032 2.145 0.0050 0.207 0.117 
Female, 55-65 year old 0.026 0.021 0.034 1.609 0.0031 0.117 0.066 
Female, 65-75 year old 0.072 0.060 0.089 1.475 0.0074 0.103 0.056 
Female, 75-85 year old 0.109 0.093 0.134 1.435 0.0100 0.092 0.050 
Female, more than 85 year old 0.087 0.059 0.110 1.852 0.0126 0.144 0.081 
Male, 35-55 year old 0.187 0.135 0.239 1.771 0.0291 0.155 0.088 
Male, 55-65 year old 0.139 0.116 0.158 1.372 0.0137 0.099 0.057 
Male, 65-75 year old 0.175 0.145 0.195 1.343 0.0139 0.079 0.042 
Male, 75-85 year old 0.134 0.105 0.159 1.510 0.0172 0.129 0.074 
Male, more than 85 year old 0.046 0.027 0.062 2.259 0.0090 0.196 0.108 
Excessive smoking 0.120 0.062 0.196 3.160 0.0350 0.293 0.164 
Alcohol problems 0.012 0.004 0.017 4.148 0.0029 0.248 0.137 
Obesity 0.063 0.018 0.111 6.273 0.0196 0.313 0.170 
Diabetes mellitus 0.155 0.092 0.208 2.254 0.0240 0.156 0.077 
Hypertension (MH) 0.299 0.203 0.373 1.833 0.0369 0.123 0.067 
Renal failure 0.050 0.028 0.078 2.760 0.0085 0.171 0.088 
Conduction disease (TC) 0.197 0.134 0.247 1.843 0.0218 0.111 0.060 
Peripheral arterial disease (AR) 0.063 0.036 0.109 3.019 0.0145 0.231 0.113 
Vascular disease (VC) 0.044 0.025 0.078 3.109 0.0108 0.248 0.128 
History of coronary artery disease (COEUR) 0.040 0.017 0.070 4.000 0.0100 0.250 0.134 
Stroke (CER) 0.032 0.020 0.048 2.448 0.0055 0.173 0.092 
Heart failure (IC) 0.158 0.128 0.204 1.598 0.0184 0.116 0.064 
Severity index (IGS) 0.283 0.143 0.438 3.054 0.0737 0.261 0.147 
Cabbage or Coronary Bypass surgery 
(CABG)  
0.009 
 
0.001 
 
0.036 
 
36.312 
 
0.0068 
 
0.740 
 
0.372 
 
Cardiac catheterization 0.190 0.130 0.271 2.081 0.0347 0.182 0.100 
Percutaneous transluminal coronary 
Angioplasty 
0.054 
 
0.010 
 
0.106 
 
10.914 
 
0.0270 
 
0.497 
 
0.277 
 
Other dilatation than PTCA 0.002 0.000 0.005 \ 0.0016 0.994 0.534 
Percutaneous revascularization 
using coronary stents (PCI – stenting) 
0.245 
 
0.107 
 
0.411 
 
3.836 
 
0.0909 
 
0.372 
 
0.206 
 
Surgical French DRGs (GHMC) 0.037 0.016 0.077 4.650 0.0154 0.418 0.232 
Source: computed from the PMSI dataset (1998-2003). Observed used to construct the disparity indices are weighted by the number of AMI 
patients. 
Table 2: disparity indices 
for the regional averages of hospital and geographic variables 
 
 
 
Mean 
 
Min 
 
Max 
 
Max/Min
 
Std. Dev. 
 
Coeff. of 
variation 
Gini 
 
Proba. of death within 1 day (KM) 0.018 0.012 0.023 1.940 0.003 0.158 0.089 
Proba. of death within 5 days (KM) 0.055 0.038 0.066 1.721 0.008 0.139 0.078 
Proba. of death within 10 days (KM) 0.088 0.061 0.107 1.749 0.011 0.122 0.067 
Proba. of death within 15 days (KM) 0.127 0.085 0.153 1.800 0.016 0.128 0.070 
Number of patients 4466 2363 9974 4.221 2235 0.501 0.231 
Number of AMI patients 386 173 968 5.585 233 0.604 0.270 
Proportion of AMI patients 0.089 0.061 0.157 2.561 0.0276 0.310 0.136 
Public 0.754 0.590 0.935 1.584 0.1002 0.133 0.076 
Not-for-profit 0.045 0.000 0.261 \ 0.0525 1.157 0.559 
For-profit 0.201 0.060 0.367 6.129 0.0855 0.426 0.242 
Unemployment rate 0.158 0.126 0.225 1.789 0.0282 0.178 0.098 
Poor area in the municipality 0.638 0.363 0.947 2.612 0.1944 0.305 0.173 
Municipality median income 13927 11552 17455 1.511 1601 0.115 0.060 
Proportion of beds in surgery 0.392 0.323 0.451 1.395 0.030 0.076 0.043 
Number of beds in surgery 753 243 3172 13.062 939 1.246 0.469 
Proportion of surgery occupied beds 0.855 0.781 0.901 1.153 0.0318 0.037 0.021 
Number of beds 1933 595 8488 14.253 2538 1.313 0.487 
Proportion of occupied beds 0.819 0.774 0.865 1.118 0.0247 0.030 0.017 
Number of beds in the urban area 8251 1107 47033 42.475 15016 1.820 0.664 
Herfindahl index for hospitals in the 
urban area 
0.592 
 
0.130 
 
0.893 
 
6.874 
 
0.226 
 
0.382 
 
0.206 
 
Source: computed from the PMSI, the SAE, and the municipality datasets (1998-2003). Observed used to construct the disparity indices are 
weighted by the number of AMI patients. 
Table 3: estimated coefficients for the individual variables 
 
Variable Estimate 
Female, 55-65 year old 
0.5426*** 
(0.1113) 
Female, 65-75 year old 
1.0444*** 
(0.0965) 
Female, 75-85 year old 
1.3935*** 
(0.0943) 
Female, more than 85 year old 
1.7681*** 
(0.0941) 
Male, 35-55 year old 
-0.3561*** 
(0.1015) 
Male, 55-65 year old 
0.2313** 
(0.0986) 
Male, 65-75 year old 
0.8173*** 
(0.0948) 
Male, 75-85 year old 
1.2867*** 
(0.0941) 
Male, more than 85 year old 
1.6713*** 
(0.0948) 
Excessive smoking 
-0.4751*** 
(0.0410) 
Alcohol problems 
0.3311*** 
(0.0654) 
Obesity 
-0.2424*** 
(0.0413) 
Diabetes mellitus 
-0.0595*** 
(0.0180) 
Hypertension (MH) 
-0.5795*** 
(0.0155) 
Renal failure 
0.3636*** 
(0.0183) 
Conduction disease (TC) 
0.8490*** 
(0.0126) 
Peripheral arterial disease (AR) 
-0.033 
(0.0242) 
Vascular disease (VC) 
-0.4508*** 
(0.0282) 
History of coronary artery disease (COEUR) 
-0.2408*** 
(0.0290) 
Stroke (CER) 
0.2967*** 
(0.0237) 
Heart failure (IC) 
0.0569*** 
(0.0134) 
Severity index (IGS) 
0.1105*** 
(0.0148) 
Cabbage or Coronary Bypass surgery (CABG)  
-0.7477*** 
(0.0853) 
Cardiac catheterization 
-1.2587*** 
(0.0299) 
Percutaneous Transluminal Coronary Angioplasty 
-0.6760*** 
(0.0385) 
Other dilatation than PTCA 
-0.874*** 
(0.2181) 
Percutaneous revascularization using coronary stents (PCI – stenting) 
-1.0207*** 
(0.0261) 
Surgical French DRGs (GHMC) 
0.2852*** 
(0.0358) 
Source: computed from the PMSI dataset (1998-2003). Note: ***: significant at 1%; **: significant at 5%; *: significant at 10%. Number of 
observations: 341, 861; mean log-likelihood: -0.449369. 
Table 4: disparity indices 
for the regional probability to die obtained from the model 
 
 
Mean 
 
Min 
 
Max 
 
Max/Min
 
Std. Dev. 
 
Coeff. of 
variation 
Gini 
 
Probability of death within 1 day 0.019 0.015 0.024 1.549 0.002 0.098 0.053 
Probability of death within 5 days 0.057 0.050 0.073 1.458 0.005 0.084 0.043 
Probability of death within 10 days 0.086 0.074 0.108 1.449 0.008 0.089 0.047 
Probability of death within 15 days 0.116 0.098 0.144 1.471 0.013 0.108 0.058 
Source: computed from the PMSI dataset (1998-2003). Note: for a given region, the survival function is constructed as the regional average 
of the model survival functions computed for every hospitals located within the region. 
 
Table 5: regression of hospital fixed effects on hospital and geographic variables 
 
Variable Regression (1) Regression (2) Regression (3) 
Constant -5.917*** 
(0.216) 
-6.195*** 
(1.445) 
-7.003*** 
(1.517) 
For-profit hospital 0.286*** 
(0.041) 
 0.014 
(0.056) 
Not-for-profit hospital 0.016 
(0.071) 
 -0.166** 
(0.075) 
Proportion of AMI patients in the hospital -1.049*** 
(0.175) 
 -0.468** 
(0.234) 
Number of beds (in log) 0.107*** 
(0.016) 
 0.006 
(0.024) 
Occupation rate of beds 0.144 
(0.223) 
 0.197 
(0.224) 
Proportion of beds in surgery -0.142 
(0.090) 
 -0.303*** 
(0.091) 
Occupation rate of beds in surgery -0.263 
(0.161) 
 -0.267* 
(0.157) 
Median municipality income  0.074 
(0.148) 
0.177 
(0.155) 
Presence of a poor area in the municipality  0.079** 
(0.031) 
0.065** 
(0.031) 
Municipality unemployment rate  -0.321 
(0.565) 
0.046 
(0.583) 
Number of beds in the urban area 
 
 0.064*** 
(0.022) 
0.061** 
(0.027) 
Herfindahl index for the healthcare structure  -0.250*** 
(0.089) 
-0.283*** 
(0.094) 
Regional dummies Non Oui Oui 
Number of hospitals 789 834 789 
Corresponding number of patients 332,827 333,810 332,827 
Adjusted-R² 0.201 0.230 0.282 
Source: computed from the PMSI, the SAE, and the municipality datasets (1998-2003).  Note: ***: significant at 1%; **: significant at 5%; 
*: significant at 10%. We introduced a dummy for the municipality not to be in an urban area (dummy for rural area), and a dummy for the 
municipality to be related to several urban areas (dummy for multi-polarized municipality). 
Table 6a: variance analysis at the regional level (first stage) 
 
 
Group of variables from which we consider the effect Variance Correlation with the 
integrated hazard 
Integrated hazard .036856 1.000 
Individual variables (averaged at the regional level) .028623 .898 
     Innovative treatments .010155 .740 
     Non-innovative treatments .000039 -.136 
     Diagnoses .002114 .396 
     Demographic variables (age x sex) .005198 .833 
Log-hospital fixed effects (averaged at the regional level) .007159 .475 
Source: computed from the PMSI, the SAE, and the municipality datasets (1998-2003).   
 
Table 6b: variance analysis at the regional level (third stage) 
 
 
Group of variables from which we consider the effect Variance Corr. with 
log-hosp. 
fixed 
effects 
Correlation 
with the 
integrated 
hazard 
Log-hospital fixed effects (averaged at the regional level) .007159 1.000 .475 
Hospital and geographic variables (averaged at the regional level) .006012 .987 .403 
     Hospital variables .000400 .106 .738 
          Status and mode of reimbursement .000078 .319 .624 
          Proportion of AMI patients .000110 .083 .387 
          Beds (capacity and occupation rate) .000136 -.012 .444 
    Geographic Variables .006319 .939 .210 
          Municipality variables  .010411 .193 -.448 
               Income-related variables .000096 -.512 -.290 
               Dummies for the municipality to be rural or multi-polarized .000137 .086 -.410 
               Number of beds in the urban area .002314 .236 -.284 
               Herfindahl index for healthcare structure .002333 .353 -.357 
          Regional dummies .010347 .541 .614 
Source: computed from the PMSI, the SAE, and the municipality datasets (1998-2003).   
      
Graph 1: Regional proportions of patients treated by for-profit hospitals 
 
 
Graph 2: Regional proportions of patients treated with stents 
 
 
Graph 3: Regional probabilities to die within fifteen days (in %) 
 
 
Note: for a given region, the probability to die is constructed as one minus the regional average of Kaplan-Meier estimators computed for 
every hospitals located within the region.  
 
 
Graph 4: Sample of regional survival functions (Kaplan-Meier) 
 
 
Source: computed from the PMSI dataset (1998-2003). Note: for a given region, the survival function is constructed as the regional average 
of Kaplan-Meier estimators computed for every hospitals located within the region. 
 
 
Graph 5: Sample of regional survival functions (model) 
 
 
Source: computed from the PMSI dataset (1998-2003). Note: for a given region, the survival function is constructed as the regional average 
of the model survival functions computed for every hospitals located within the region. 
 
 
Graph 6: Baseline instantaneous hazard for exit to death 
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Source: computed from the PMSI dataset (1998-2003).   
Appendix 
 
Table A1: regional probability to die within 15 days (Kaplan-Meier) 
 
 
Region code Name Probability to die 
91 Languedoc-Roussillon 15.31% 
22 Picardie 15.28% 
25 Basse-Normandie 14.48% 
53 Bretagne 14.45% 
73 Midi-Pyrénées 13.97%  
52 Pays de la Loire 13.67% 
72 Aquitaine 13.64% 
24 Centre 13.51% 
83 Auvergne 13.46% 
21 Champagne-Ardenne 12.96% 
93 Provence – Alpes Côte d’Azur 12.93% 
54 Poitou–Charentes 12.87% 
31 Nord-Pas-de-Calais 12.73% 
26 Bourgogne 12.71% 
23 Haute-Normandie 12.60% 
43 Franche-Comté 12.13% 
82 Rhône-Alpes 12.03% 
74 Limousin 11.88% 
41 Lorraine 11.67% 
11 Ile-de-France 9.93% 
42 Alsace 8.51% 
Source: computed from the PMSI dataset (1998-2003). Note: for a given region, the probability to die is equal to one minus the survival 
function. An estimator of this survival function is constructed as the regional average of Kaplan-Meier estimators computed for every 
hospitals located within the region.  
 
Table A2: regional probability to die within 15 days (model) 
 
 
Numéro de région Nom Probability to die 
91 Languedoc-Roussillon 14.40%       (1) 
72 Aquitaine 13.95%       (7) 
93 Provence – Alpes Côte d’Azur 11.06%     (11) 
83 Auvergne 12.85%       (9) 
22 Picardie 12.00%       (2) 
31 Nord-Pas-de-Calais 11.92%     (13) 
24 Centre 11.68%       (8) 
73 Midi-Pyrénées 11.68%       (5) 
53 Bretagne 11.25%       (4) 
25 Basse-Normandie 11.13%       (3) 
82 Rhône-Alpes 11.11%     (17) 
11 Ile-de-France 11.06%     (20) 
41 Lorraine 11.03%     (19) 
43 Franche-Comté 10.81%     (16) 
52 Pays de la Loire 10.60%       (6) 
21 Champagne-Ardenne 10.59%     (10) 
23 Haute-Normandie 10.47%     (15) 
74 Limousin   9.92%     (18) 
54 Poitou–Charentes   9.87%     (12) 
26 Bourgogne   9.85%     (14) 
42 Alsace   9.84%     (21) 
Source: computed from the PMSI dataset (1998-2003). Note: for a given region, for a given region, the probability to die is equal to one 
minus the survival function. An estimator of this survival function is constructed as the regional average of the model survival functions 
computed for every hospitals located within the region. In the last column, the ranking of the regions obtained from raw data is reported in 
parenthesis. 
Table A3: regression of hospital fixed effects on aggregated variables, 
innovative treatments are not controlled for 
 
Variable Regression (1) Regression (2) Regression (3) 
Constant -4.926*** 
(0.200) 
-5.518*** 
(1.400) 
-5.838*** 
(1.439) 
For-profit hospital -0.211*** 
(0.038) 
 -0.220*** 
(0.053) 
Not-for-profit hospital -0.257*** 
(0.066) 
 -0.232*** 
(0.071) 
Proportion of AMI patients in the hospital -0.604*** 
(0.162) 
 -0.491** 
(0.222) 
Number of beds (in log) -0.012 
(0.015) 
 -0.009 
(0.023) 
Occupation rate of beds -0.049 
(0.207) 
 -0.115 
(0.212) 
Proportion of beds in surgery -0.296*** 
(0.084) 
 -0.284*** 
(0.086) 
Occupation rate of beds in surgery -0.101 
(0.150) 
 -0.127 
(0.150) 
Median municipality income  0.071 
(0.143) 
0.172 
(0.147) 
Presence of a poor area in the municipality  0.010 
(0.030) 
0.001 
(0.030) 
Municipality unemployment rate  0.242 
(0.547) 
0.437 
(0.551) 
Number of beds in the urban area 
 
 -0.043** 
(0.021) 
-0.052** 
(0.026) 
Herfindahl index for the healthcare structure  -0.087 
(0.086) 
-0.275*** 
(0.088) 
Regional dummies Non Oui Oui 
Number of hospitals 789 834 789 
Corresponding number of patients 332,827 333,810 332,827 
Adjusted-R² 0.159 0.155 0.270 
Source: computed from the PMSI, the SAE, and the municipality datasets (1998-2003). Note: ***: significant at 1%; **: significant at 5%; 
*: significant at 10%. We introduced a dummy for the municipality not to be in an urban area (dummy for rural area), and a dummy for the 
municipality to be related to several urban areas (dummy for multi-polarized municipality). 
Table A4: regional dummies obtained from the hospital fixed-effect regression 
 
 
Region code Name Coefficient 
91 
 
Languedoc-Roussillon 
 
< Reference > 
 
(1) 
 
25 
Basse-Normandie 
 
-0.170* 
(0.090) 
(3) 
 
41 
Lorraine 
 
-0.174** 
(0.088) 
(19) 
 
22 
Picardie 
 
-0.181** 
(0.086) 
(2) 
 
53 
Bretagne 
 
-0.181** 
(0.080) 
(4) 
 
72 
Aquitaine 
 
-0.189** 
(0.075) 
(7) 
 
21 
Champagne-Ardenne 
 
-0.227** 
(0.090) 
(10) 
 
93 
Provence – Alpes Côte d’Azur 
 
-0.228*** 
(0.071) 
(11) 
 
26 
Bourgogne 
 
-0.228** 
(0.088) 
(4) 
 
24 
Centre 
 
-0.229*** 
(0.083) 
(8) 
 
74 
Limousin 
 
-0.233** 
(0.102) 
(18) 
 
83 
Auvergne 
 
-0.233*** 
(0.089) 
(9) 
 
43 
Franche-Comté 
 
-0.242** 
(0.101) 
(16) 
 
54 
Poitou–Charentes 
 
-0.242*** 
(0.087) 
(12) 
 
52 
Pays de la Loire 
 
-0.261*** 
(0.079) 
(6) 
 
82 
Rhône-Alpes 
 
-0.264*** 
(0.074) 
(17) 
 
73 
Midi-Pyrénées 
 
-0.267*** 
(0.077) 
(5) 
 
31 
Nord-Pas-de-Calais 
 
-0.284*** 
(0.070) 
(13) 
 
42 
Alsace 
 
-0.294*** 
(0.098) 
(21) 
 
23 
Haute-Normandie 
 
-0.316*** 
(0.087) 
(15) 
 
11 
Ile-de-France 
 
-0.583*** 
(0.108) 
(20) 
 
Source: computed from the PMSI, the SAE, and the municipality datasets (1998-2003). Note: in the last column, the ranking of the regions 
obtained from raw data is reported in parenthesis. 
 
Graph A1: Map of the French Regions 
 
 
Regions. 11: Ile-de-France; 21: Champagne-Ardenne; 22: Picardie; 23: Haute-Normandie; 24: Centre; 25: Basse-Normandie; 26: 
Bourgogne; 31: Nord Pas-de-Calais; 41: Lorraine; 42: Alsace; 43: Franche-Comté; 52: Pays de la Loire; 53: Bretagne; 54: Poitou-
Charentes; 72: Aquitaine; 73: Midi-Pyrénées; 74: Limousin; 82: Rhônes-Alpes; 83: Auvergne; 91: Languedoc-Roussillon; 93: Provence - 
Alpes Côtes d’Azur. 
 
 
 
Graph A2: Regional survival functions (Kaplan-Meier) 
 
 
Source: computed from the PMSI dataset (1998-2003).  Note: for a given region, the survival function is constructed as the regional average 
of Kaplan-Meier estimators computed for every hospitals located within the region. 
Graph A3: Regional survival functions (model) 
 
 
Source: computed from the PMSI dataset (1998-2003).  Note: for a given region, the survival function is constructed as the regional average 
of the model survival functions computed for every hospitals located within the region. 
 
